These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28892433)

  • 1. Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.
    Østgård LSG; Nørgaard M; Medeiros BC; Friis LS; Schoellkopf C; Severinsen MT; Marcher CW; Nørgaard JM
    J Clin Oncol; 2017 Nov; 35(32):3678-3687. PubMed ID: 28892433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
    Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
    Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients.
    Østgård LS; Nørgaard M; Sengeløv H; Medeiros BC; Kjeldsen L; Overgaard UM; Severinsen MT; Marcher CW; Jensen MK; Nørgaard JM
    Oncotarget; 2016 Nov; 7(44):72044-72056. PubMed ID: 27732947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
    J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden.
    Kristinsson SY; Derolf AR; Edgren G; Dickman PW; Björkholm M
    J Clin Oncol; 2009 Apr; 27(12):2073-80. PubMed ID: 19289627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial.
    Pfirrmann M; Ehninger G; Thiede C; Bornhäuser M; Kramer M; Röllig C; Hasford J; Schaich M;
    Lancet Oncol; 2012 Feb; 13(2):207-14. PubMed ID: 22197676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early mortality and overall survival of acute myeloid leukemia based on facility type.
    Bhatt VR; Shostrom V; Giri S; Gundabolu K; Monirul Islam KM; Appelbaum FR; Maness LJ
    Am J Hematol; 2017 Aug; 92(8):764-771. PubMed ID: 28437868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia.
    Rodriguez CP; Baz R; Jawde RA; Rybicki LA; Kalaycio ME; Advani A; Sobecks R; Sekeres MA
    Leuk Res; 2008 Mar; 32(3):413-20. PubMed ID: 17727945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.
    Canaani J; Beohou E; Labopin M; Socié G; Huynh A; Volin L; Cornelissen J; Milpied N; Gedde-Dahl T; Deconinck E; Fegueux N; Blaise D; Mohty M; Nagler A
    Am J Hematol; 2017 Apr; 92(4):344-350. PubMed ID: 28052366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low- and middle-income countries (LMIC): A Brazilian experience.
    Benicio MTL; Ribeiro AFT; Américo AD; Furtado FM; Glória AB; Lima AS; Santos SM; Xavier SG; Lucena-Araujo AR; Fagundes EM; Rego EM
    Leuk Res; 2017 Sep; 60():109-114. PubMed ID: 28777950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonbiological factors affecting survival in younger patients with acute myeloid leukemia.
    Borate UM; Mineishi S; Costa LJ
    Cancer; 2015 Nov; 121(21):3877-84. PubMed ID: 26367383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
    Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
    Juliusson G; Karlsson K; Lazarevic VLj; Wahlin A; Brune M; Antunovic P; Derolf A; Hägglund H; Karbach H; Lehmann S; Möllgård L; Stockelberg D; Hallböök H; Höglund M;
    Cancer; 2011 Sep; 117(18):4238-46. PubMed ID: 21387283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.
    Michelis FV; Messner HA; Atenafu EG; McGillis L; Lambie A; Uhm J; Alam N; Seftel MD; Gupta V; Kuruvilla J; Lipton JH; Kim DD
    Bone Marrow Transplant; 2015 Nov; 50(11):1405-10. PubMed ID: 26168067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.